PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

New Galanin Analogues with Contractile Activities on Rat Gastric Smooth MusclesR

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
We synthesized new 15-amino-acid-residue analogues of porcine galaninmodified in positions 2, 6, 8 or 14 and studied their activity on isolated rat gastric smooth muscles. Thus, we intended to characterize the molecular domains of GAL responsible for binding to its receptors and biological activity in the gastric fundus. All peptides were synthesized by the solid phase peptide synthesis with the use of Fmoc strategy. All galanin analogues contracted rat gastric fundus strips in a concentration-dependent manner with significantly increased or decreased activities as compared to GAL(1-15)NH2. As expected, the modifications introduced into the amino acid sequence of galanin caused changes in the interaction of GAL(1-15)NH2 with its receptors. Thus, residues: Trp2, Ser6, Gly8 and His14 in the amino acid sequence of GAL(1-15)NH2 play an important roles in the high-affinity binding of GAL to its receptors and biological activity in rat gastric smooth muscle cells.
Rocznik
Strony
57--66
Opis fizyczny
Bibliogr. 36 poz., rys.
Twórcy
  • Faculty of Chemistry, University of Gdansk, Sobieskiego 18, 80-952 Gdansk, Poland
autor
  • Faculty of Chemistry, University of Gdansk, Sobieskiego 18, 80-952 Gdansk, Poland
  • Department of Pharmacology, Medical University of Gdańsk Do Studzienki 38, 80-227 Gdańsk Poland
  • Department of Pharmacology, Medical University ofGdańsk Do Studzienki 37, 80-227 Gdańsk Poland
autor
  • Faculty of Chemistry, University of Gdansk, Sobieskiego 18, 80-952 Gdansk, Poland
Bibliografia
  • 1. Tatemoto K., Rökaeus Ä., Jörnvall H., McDonald T.J. and Mutt V., FEBS Lett., 164, 124 (1983).
  • 2. Kaplan L.M., Spindel E.R., Isselbacher K.J., and Chin W.W., Proc, Natl. Acad. Sci. USA 85 1065 (1988).
  • 3. Rökaeus A. and Carlquist M., FEBS Lett., 234, 400 (1988).
  • 4. Vrontakis M.E., Peden L.M., Duchworth M.L. and Friesen H.G., J. Biol. Chem., 262, 16755 (1987).
  • 5. Norberg Ä., Sillard R, Carlquist M., Jörnvall H. and Mutt V., FEBS Lett., 288, 151 (1991).
  • 6. Schmidt W.E., Kratzin H., Eckart K., Drevs D., Mundkowski G., Clemens A., Katsoulis S., Schafer H., Gallwitz B. and Creutzfeldt W., Proc. Natl. Acad. Sci. USA, 88, 11435 (1991).
  • 7. Anglade l., Wang Y.X., Jensen J., Tramu G., Kah O. and Conlon J.M., J. Comp. Neurol, 350,63 (1994).
  • 8. Langel Ü. and Bartfai T., Arm. N. Y. Acad. Sei., 863, 86 (1998).
  • 9. Crawley J.N., Regul. Pept., 59, 1 (1995).
  • 10. Bedecs K., Berthold M. and Bartfai T., Int. J. Biochem. Cell. Biol., 27, 337 (1997).
  • 11. Bartfai T., Fisone G. and Langel Ü., TIPS, 13, 312 (1992).
  • 12. Bartfai T. and Langel Ü., Ear. J. Med. Chem., 30, 163S (1995).
  • 13. Branchek T. A, Smith K.E, Gerald C. and Walker M., Trends Pharm. Sci., 21, 109 (2000).
  • 14. Kask K., Langel Ü. and Bartfai T., Cell. Mol. Neurobiol, 15, 653 (1995).
  • 15. Ekblad E., Rökaeus A., Häkanson R. and Sundler F., Neuroscience, 16, 355 (1985).
  • 16. Maggi C.A., Patacchini R., Santicioli P., Giuliani S., Turini D., Barbanti G., Beneforti B., Misuri D. and Meli A., Naunyn Schmiedebergs Arch. Pharmacol., 339, 415 (1989).
  • 17. Ekblad E., AmbjömssonE., Ekman R., Häkanson R. and Sundler F., Dig. Dis. Sci., 34, 1217 (1989).
  • 18. Fontaine J. and Lebrun P., Eur. J. Pharmacol., 164, 583 (1989).
  • 19. Kuwahara A., Ozaki T. and Yanaihara N., Eur. J. Pharmacol., 164, 175 (1989).
  • 20. Tamura K., Palmer J. M. and Wood J. D., Eur. J. Pharmacol., 136, 445 (1987).
  • 21. Ekblad E., Häkanson R., Sundier F. and Wahlstedt C., Br. J. Pharmacol., 86, 24! (1985).
  • 22. Fox J.E.T., Me Donald T.J., Kostolanska F. and Tatemoto K., Life Sci., 39, 103 (1986).
  • 23. Maggi C. A., Santicioli P., Patacchini R., Turini D„ Barbanti G., Beneforti B., Giuliani S. and Meli A Eur. J. Pharmacol., 143, 135 (1987).
  • 24. Ahtaridis S.A., Katoch S.S. and Moreland R.S., Am. J. Physiol., 274, G306 (1998).
  • 25. Korolkiewicz R., Konstanski Z., Rekowski P., Ruczyński J„ Szyk A., Szczepańska R., Korolkiewicz K. Z. and Petrusewicz Pharm. Pharmacol. Commun., 6, 415 (2000).
  • 26. Land T., Langel Ü., Löw M., Berthold M., Unden A. and Bartfai T., Int J. Pept. Protein Res 38 267 (1991) . ’
  • 27. Yanaihara N., Mohizuki T., Takatsuka N., Iguchi K., Sato K., Kakuyama H., Li M. and Yanaihara C. Regul. Pept., 46, 93 (1993).
  • 28. Jurćus A., Langel Ü. and Bartfai T., J. Peptide. Res., 49, 195(1997),
  • 29. Pooga M., Jureus A., Rezael K., Hasanvan H., Saar K., Kask K., Kjellen P., Land T„ Halonen J., Mäeorg U., Uri A., Solyom S., Bartfai T. and Langel Ü., J. Peptide. Res., 51, 65 (1998).
  • 30. Carpenter K.A., Schmidt R., Yue S. Y., Hodzic L., Pou C., Payza K., Godbout C., Brown W. and Roberts E Biochem., 38, 15295 (1999).
  • 31. Chan WC and White PD: Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford, Oxford University Press, 2000.
  • 32. Vane J.R., Br. J. Pharmacol, 12, 344 (1957).
  • 33. Katsoulis S., Schmidt W.E., Schworer H. and Creutzfeldt W., Br. J. Pharmacol., 101, 297 (1990).
  • 34. Śliwiński W., Korolkiewicz R., Rekowski P., Halama A. and Korolkiewicz K.Z., Fundam. Clin. Pharmacol, 10,442(1996).
  • 35. Ruczyński J., Szyk A., Konstański Z., Korolkiewicz R. and Rekowski P., Polish. J. Chem., 74, 1375 (2000).
  • 36. Korolkiewicz R., Konstański Z., Rekowski P., Ruczyński J., Szyk A., Grzybowska M., Korolkiewicz K.Z. and Petrusewicz J., J. Physiol. Pharmacol., 52(1), 127 (2001
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUJ1-0020-0007
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.